Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.
about
Pathogenic Acinetobacter: from the Cell Surface to Infinity and BeyondTreatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsAcinetobacter baumannii: evolution of antimicrobial resistance-treatment optionsStructure-guided enzymology of the lipid A acyltransferase LpxM reveals a dual activity mechanismNew amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharidesBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsEfficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumanniiTop-Down Strategies for the Structural Elucidation of Intact Gram-negative Bacterial Endotoxins.Bilayer Properties of Lipid A from Various Gram-Negative BacteriaVariation in the OC locus of Acinetobacter baumannii genomes predicts extensive structural diversity in the lipooligosaccharide.The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistanceThe presence of a galactosamine substituent on the arabinogalactan of Mycobacterium tuberculosis abrogates full maturation of human peripheral blood monocyte-derived dendritic cells and increases secretion of IL-10.Norharmane Matrix Enhances Detection of Endotoxin by MALDI-MS for Simultaneous Profiling of Pathogen, Host, and Vector Systems.A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.Bacterial strategies of resistance to antimicrobial peptides.Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.Transcriptome Remodeling of Acinetobacter baumannii during Infection and Treatment.Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii.Recognition of LPS by TLR4: potential for anti-inflammatory therapies.Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria.Antimicrobial peptide resistance in Neisseria meningitidis.Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship.Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.Novel Coordination of Lipopolysaccharide Modifications in Vibrio cholerae promotes CAMP resistance.Identification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids.Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens.In Vivo Fitness Adaptations of Colistin-Resistant Acinetobacter baumannii Isolates to Oxidative Stress.Gene expression analysis in human polymorphonuclear leukocytes stimulated by LPSs from nosocomial opportunistic pathogens.Peptide array based discovery of synthetic antimicrobial peptides.Uncovering the mechanisms of Acinetobacter baumannii virulence.Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.New Features in the Lipid A Structure of Brucella suis and Brucella abortus Lipopolysaccharide.Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii.Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin.Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens.
P2860
Q26771783-8944D6F5-3F5E-4BDC-B920-1AFDFE4A85C6Q26991886-E2AF0A6A-AA1A-49BC-815E-573566E7EB59Q27015109-7C01FB07-4829-4C6E-84AE-6900D559EA29Q27728135-B0A09AC8-287E-4EDD-8D27-DFFD02BEE803Q28654498-DB1937E3-AD12-4F73-BB72-53F03B9C7C94Q30235064-CC9235FA-DD85-4100-9D57-14CDECB40903Q34049982-D0D961F0-7378-49C4-BC6A-12F319399271Q34472499-21C35BB4-E538-4F68-A0EE-962403949957Q34543053-85B42218-A259-4BF0-9CAD-9C10F7111332Q35270634-5F5A7D99-3A3D-43A7-A16D-1BDDD6590789Q35432662-81A18151-5B92-4EC3-8268-8723408C8116Q35541353-B5241785-6023-42DD-9147-6A5E194AF86EQ35551122-58803609-6B47-4982-ACA1-4A79FEDC2FB8Q35762782-D4521712-A55F-4A5B-8C0C-954FC56304CFQ36138907-6C81823F-AF32-4E60-BD24-6332CCF1DA4FQ36290794-1AEB5201-701A-4BB7-93D2-EB1A96A57A93Q36628128-B1D7C385-8356-418A-A075-6359DF7A7D2EQ36920921-050F711C-5397-498A-87C0-3DD038256CB6Q37014270-1B349786-0176-47A2-8947-8B37779CF22CQ37346853-E04DAC72-4A3D-408D-AAE4-4FBEA2C11B68Q37685595-8FE85A05-17D3-4A0D-A45F-D0F8275512FBQ37728145-D561BE01-ED53-4FC6-8A78-64B58B0138BCQ38233314-A443AF03-5E43-439E-89B5-FC9642FBE461Q38287949-53A6D608-02F2-4B70-983D-F85101525B3AQ38499031-3DC85797-D22E-439F-B208-97C52B18540AQ38847017-48716EC0-FE6B-4C6C-A5CD-5C2A97C5E853Q39096977-843E41D3-B565-4745-A41E-0613BCDE2FEAQ39218893-3E5BB7CF-AC00-4BE5-92F9-E1054019DBD1Q40046802-FA2EF55A-D609-450C-9687-C0DFAAEFBF5CQ40119849-4657F2BF-FBF7-40A2-BEFC-F3C177DC5B68Q40266237-B1549B83-3728-4697-8999-458A55270EC5Q40403809-0CEFA15C-4419-4E7C-B67B-B468960CC73BQ40996390-AA604822-A58B-4BDA-9A4F-D8507F13B4B1Q42776890-F0F4FA4E-1529-4002-A59A-813CC671F494Q46237978-E34B2E31-0E94-435C-B7DF-323EE7E35CC1Q46271352-1BABB431-B4FF-4D1F-8769-BA0DE3CD0BF8Q46304715-FAD8EA7F-4BB1-445C-8997-9854A96E8855Q47136007-8A3D7A42-E013-429F-A6BF-DB879C8ECD30Q48346122-F37B09B7-4729-4C3E-8B41-212139704E17Q52715802-141BB300-9768-41FD-AF3E-3E57393C4077
P2860
Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Unique structural modification ...... ns of Acinetobacter baumannii.
@en
Unique structural modification ...... ns of Acinetobacter baumannii.
@nl
type
label
Unique structural modification ...... ns of Acinetobacter baumannii.
@en
Unique structural modification ...... ns of Acinetobacter baumannii.
@nl
prefLabel
Unique structural modification ...... ns of Acinetobacter baumannii.
@en
Unique structural modification ...... ns of Acinetobacter baumannii.
@nl
P2093
P2860
P356
P1476
Unique structural modification ...... ins of Acinetobacter baumannii
@en
P2093
Jace W Jones
Karsten R O Hazlett
Leila G Casella
Mark D Adams
Mark R Pelletier
Robert K Ernst
P2860
P304
P356
10.1128/AAC.00865-13
P407
P577
2013-07-22T00:00:00Z